One’s Fosse Way View Care Home in Bingham, Nottingham, recently came together for a heartfelt and inspiring fundraiser in ...

People in early stages of the disease may show other signs of cognitive deterioration such as being unable to follow ...

Alzheimer's disease (AD) is a progressive brain disease that leads to problems with cognitive abilities such as thinking, memory, language, and learning.

Alzheimer’s disease is a progressive form of dementia that affects memory, thinking, and behavior. Learn about the causes, symptoms, treatments, and more.

Tulane University researchers created a first-of-its-kind subcellular map of an area of the brain commonly affected by Alzheimer’s disease, a key step toward unraveling the mysteries of how the degene ...

UCLA Health researchers have identified four distinct pathways that lead to Alzheimer's disease by analyzing electronic ...

The Alzheimer's Association recommends against use outside of a research or clinical setting. Read Part 1 of this series: For Your Patients: What Is Alzheimer's Disease?

A team of researchers at the Sant Pau Research Institute (IR Sant Pau) has demonstrated that the plasma biomarker p-tau217, ...

A new UVA study finds that HIV drugs like NRTIs may reduce Alzheimer's risk by 10% annually, suggesting potential for repurposing in dementia prevention.

A new study has found that a common class of medications could dramatically decrease the risk of developing Alzheimer's disease.

A new survey from the Alzheimer's Association finds that people want to know if they are in the early stages of the disease, and are open to drug treatment.

In 2018, the cost of caring for those with Alzheimer’s and other dementias was estimated at $277 billion. By 2050, it could hit $1.1 trillion.